SCHEMBL7307517

SCHEMBL7307517

COc1ccc(SC(CC2CCCC2)C(C(=O)NO)C(C)C)cc1

nearest known ligand 0.43

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ADAM17 P78536 4/20 0.43
ALDH1A1 P00352 2/20 0.43
MMP13 P45452 5/20 0.42
MMP9 P14780 2/20 0.42
MMP1 P03956 7/20 0.42
MMP3 P08254 6/20 0.42
MMP2 P08253 5/20 0.42
MMP8 P22894 2/20 0.42
EPHX2 P34913 1/20 0.41
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
CHRM2 P08172 1/20 0.39
KLK7 P49862 2/20 0.39
CTSK P43235 1/20 0.39
BMP1 P13497 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7302605 0.87 ALDH1A1 (0.41) ALDH1A1EPHX2MEN1KMT2ACHRM2
SCHEMBL7308312 0.87 ALDH1A1 (0.41) ADAM17ALDH1A1MMP13MMP9MMP1
SCHEMBL7302606 0.77 MMP1 (0.56) ADAM17ALDH1A1MMP13MMP9MMP1
SCHEMBL7298812 0.76 MMP1 (0.42) ADAM17ALDH1A1MMP13MMP9MMP1
SCHEMBL7308194 0.76 MMP3 (0.53) ADAM17ALDH1A1MMP13MMP9MMP1
SCHEMBL7308949 0.74 ADAM17 (0.48) ADAM17ALDH1A1MMP13MMP9MMP1
SCHEMBL27464871 0.73 MMP13 (0.48) ADAM17ALDH1A1MMP13MMP9MMP1
SCHEMBL7304794 0.72 EPHX2 (0.43) ALDH1A1MMP1MMP3MMP2EPHX2
SCHEMBL6930628 0.71 ADAM17 (0.64) ADAM17ALDH1A1MMP13MMP9MMP1
SCHEMBL6934693 0.71 ALDH1A1 (0.60) ADAM17ALDH1A1MMP13MMP9MMP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0780386-B1 Matrix metalloprotease inhibitors HOFFMANN LA ROCHE (CH) 2002-10-02 EP disclosed
US-5932595-A ANTIARTHRITIC AGENT; MULTIPLE SCLEROSIS; OSTEOPOROSIS; RESPIRATORY SYSTEM DISORDERS; SKIN DISORDERS; ANTIULCER AGENT SYNTEX (U.S.A.) INC. (US) 1999-08-03 US disclosed
EP-0780386-A1 Matrix metalloprotease inhibitors F. HOFFMANN-LA ROCHE AG (CH) 1997-06-25 EP disclosed